Market revenue in 2023 | USD 475.6 million |
Market revenue in 2030 | USD 795.4 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Viscosupplementation agents |
Fastest growing segment | Viscosupplementation Agents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Others Drug Type |
Key market players worldwide | GlaxoSmithKline Consumer Healthcare (GSK CH India), Sanofi SA, Pfizer Inc, Bayer AG, Zimmer Biomet Holdings Inc, Novartis AG ADR, Anika Therapeutics Inc, Assertio Holdings Inc, Bioventus Inc Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis therapeutics market will help companies and investors design strategic landscapes.
Viscosupplementation agents was the largest segment with a revenue share of 36.63% in 2023. Horizon Databook has segmented the Japan osteoarthritis therapeutics market based on viscosupplementation agents, nonsteroidal anti-inflammatory drugs, analgesics, corticosteroids, others drug type covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan osteoarthritis therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Japan osteoarthritis therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account